NovaBioAssays

Executive Summary

NovaBioAssays is a San Diego-based contract research organization (CRO) specializing in analytical and bioanalytical solutions for drug discovery and development. Founded in 2018, the company supports a wide range of therapeutic modalities including proteins, antibodies, ADCs, oligonucleotides, small molecules, and gene therapies. By delivering high-quality data and strategic partnerships, NovaBioAssays aims to accelerate clients' pipeline progression while reducing development costs. The company's comprehensive service suite positions it as a valuable partner for pharmaceutical and biotech firms seeking reliable outsourcing for complex bioanalysis. As the CRO market continues to expand, NovaBioAssays is well-positioned to capture growth driven by increasing R&D outsourcing and the rise of novel therapeutic modalities.

Upcoming Catalysts (preview)

• Q4 2026Expansion of gene therapy bioanalytical services70% success
• Q2 2027Key partnership with a top-20 pharma company50% success
• Q1 2027Launch of new oligonucleotide analysis platform60% success